British pharmaceutical giant AstraZeneca has secured NHS approval for its groundbreaking breast cancer drug capivasertib, marking a significant milestone in oncology treatment. The twice-daily tablet, developed in Cambridge, demonstrates remarkable
All posts tagged in breast cancer treatment
2Articles
In a significant development for the UK healthcare sector, the NHS has announced the introduction of a groundbreaking once-daily tablet for advanced breast cancer treatment. This strategic move is projected
